BioVinc Secures Multi-Million Dollar SBIR Fast-Track Grant from NIH/NIAID to Advance Treatment for Infected Fractures
BioVinc is thrilled to announce it has been awarded a prestigious multi-million dollar SBIR Fast-Track Phase I/II grant from the National Institutes of Health (NIH/NIAID). This funding will accelerate our research and development of cutting-edge treatments targeting infected fractures, a critical unmet medical need. Patients suffering from open fractures face an alarmingly high risk of…